Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human interleukin-7

EU orphan designation number: EU/3/12/1013   
Active ingredient: Recombinant human interleukin-7
Indication: Treatment of progressive multifocal leukoencephalopathy
Sponsor: Inserm-ANRS (Agence Nationale de Recherches sur le Sida et les Hépatites Virales)
101 rue de Tolbiac, 75013 Paris, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Centralised Orphan - Designation EMA/OD/011/12 (2012)4767 of 04/07/2012
03/06/2014 Centralised Orphan - Transfer of orphan designation EMA/OD/011/12/T/01 (2014)3382 of 15/05/2014